3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
2
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Rectal Neoplasms
1
Polyps
1
Neoplastic Syndromes, Hereditary
1
Neoplasms, Germ Cell and Embryonal
1
Medulloblastoma
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Hepatoblastoma
1
Genetic Diseases, Inborn
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Barrett Esophagus
1
Adenomatous Polyps
1
Adenomatous Polyposis Coli
1
Adenoma
1
Interventions
Oxaliplatin
4
Fluorouracil
4
Magnetic Resonance Spectroscopy
3
5,10-methylenetetrahydrofolic acid
3
Ocoxin
2
Leucovorin
2
Irinotecan
2
Cyclophosphamide
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
sintilimab
1
pralsetinib
1
pembrolizumab
1
napabucasin
1
huachansu
1
guadecitabine
1
Ursodeoxycholic Acid
1
Surveys and Questionnaires
1
S-1 plus cisplatin
1
Pharmaceutical Preparations
1
Pemetrexed
1
Paclitaxel
1
Oviposition
1
Levoleucovorin
1
Infliximab
1
Imatinib Mesylate
1
Gemcitabine
1
Exercise Test
1
Drainage
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Gastrointestinal Diseases
×
Ursodeoxycholic Acid
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled